A phase III, intergroup, randomized, double-blind, chemoprevention trial of selenium (Se) supplementation in resected stage I non-small cell lung cancer (NSCLC) Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Karp, DD
  • Lee, SJ
  • Wright, GL Shaw
  • Johnson, DH
  • Johnston, MR
  • Goodman, GE
  • Clamon, GH
  • Okawara, Gordon
  • Marks, R
  • Ruckdeschel, JC

publication date

  • June 20, 2010